Bill Title: As enacted, authorizes a pharmaceutical manufacturer or its representatives to engage in truthful promotion of off-label uses. - Amends TCA Title 4; Title 7; Title 33; Title 53; Title 63; Title 68 and Title 71.

Spectrum: Slight Partisan Bill (Republican 3-1)

Status: (Passed) 2018-05-08 - Pub. Ch. 893 [HB2220 Detail]

Text: Latest bill text (Chaptered) [PDF]

---

PolitiCorps Conversations

Start PolitiCorps Debate

Title	PolitiCorps	Access	Comments	Views	Last Post
There are no visible public or private PolitiCorps discussions concerning the 2017 Tennessee HB2220 at this time.

Social Comments on TN HB2220